449 related articles for article (PubMed ID: 20302663)
1. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
[TBL] [Abstract][Full Text] [Related]
3. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis.
Di Paola R; Talero E; Galuppo M; Mazzon E; Bramanti P; Motilva V; Cuzzocrea S
Respir Res; 2011 Apr; 12(1):41. PubMed ID: 21477302
[TBL] [Abstract][Full Text] [Related]
5. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
6. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
7. Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Shimaoka Y; Tajima S; Fujimori F; Yamabayashi C; Moriyama H; Terada M; Takada T; Suzuki E; Bando M; Sugiyama Y; Narita I
Lung; 2009; 187(5):331-9. PubMed ID: 19672658
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
9. Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Venosa A; Gow JG; Taylor S; Golden TN; Murray A; Abramova E; Malaviya R; Laskin DL; Gow AJ
Toxicol Appl Pharmacol; 2021 Apr; 417():115470. PubMed ID: 33647319
[TBL] [Abstract][Full Text] [Related]
10. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
11. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
[TBL] [Abstract][Full Text] [Related]
12. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
[TBL] [Abstract][Full Text] [Related]
13. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
14. Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process.
Chen C; Wang YY; Wang YX; Cheng MQ; Yin JB; Zhang X; Hong ZP
Biochem Biophys Res Commun; 2018 Jan; 495(4):2396-2403. PubMed ID: 29278701
[TBL] [Abstract][Full Text] [Related]
15. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
16. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.
Baowen Q; Yulin Z; Xin W; Wenjing X; Hao Z; Zhizhi C; Xingmei D; Xia Z; Yuquan W; Lijuan C
Eur J Pharmacol; 2010 Sep; 642(1-3):134-9. PubMed ID: 20510684
[TBL] [Abstract][Full Text] [Related]
17. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
[TBL] [Abstract][Full Text] [Related]
18. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
19. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]